{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Gilley SP"],"funding":["Eunice Kennedy Shriver National Institute of Child Health and Human Development","NICHD NIH HHS","U.S. Department of Agriculture","Gates Foundation","USDA Agricultural Research Service"],"pagination":["101279"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12863136"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["156(2)"],"pubmed_abstract":["<h4>Background</h4>Maternal selenium deficiency is hypothesized to contribute to risk of adverse outcomes including low birth weight and prematurity, possibly through its role as an antioxidant and/or in thyroid hormone function.<h4>Objectives</h4>We assessed relationships between maternal selenium concentrations during pregnancy with offspring outcomes including birth measurements, low birth weight (<2500 g), prematurity (<37 wk), and small for gestational age (birth weight <10th percentile for gestational age).<h4>Methods</h4>This was a secondary analysis of the Women First Trial (NCT01883193), a randomized controlled study investigating the effect of small-quantity lipid-based nutrition supplement (sqLNS) with 130 μg selenium on fetal growth. sqLNS was started ≥3 mo prior to conception,"],"journal":["The Journal of nutrition"],"pubmed_title":["A Multicountry Analysis of Maternal Selenium Status in Pregnancy and Lactation and Infant Birth Outcomes: Findings from the Women First Maternal Preconception Study."],"pmcid":["PMC12863136"],"funding_grant_id":["U10 HD076474"],"pubmed_authors":["Garces A","Westcott JL","Goldenberg RL","Goudar S","McClure EM","Long JM","Shankar K","Saleem S","Gilley SP","Hambidge KM","Women First Trial Group","Somannavar MS","Krebs NF","Das A","Ali SA","Kemp JF","Derman Lester Figueroa RJ"],"additional_accession":[]},"is_claimable":false,"name":"A Multicountry Analysis of Maternal Selenium Status in Pregnancy and Lactation and Infant Birth Outcomes: Findings from the Women First Maternal Preconception Study.","description":"<h4>Background</h4>Maternal selenium deficiency is hypothesized to contribute to risk of adverse outcomes including low birth weight and prematurity, possibly through its role as an antioxidant and/or in thyroid hormone function.<h4>Objectives</h4>We assessed relationships between maternal selenium concentrations during pregnancy with offspring outcomes including birth measurements, low birth weight (<2500 g), prematurity (<37 wk), and small for gestational age (birth weight <10th percentile for gestational age).<h4>Methods</h4>This was a secondary analysis of the Women First Trial (NCT01883193), a randomized controlled study investigating the effect of small-quantity lipid-based nutrition supplement (sqLNS) with 130 μg selenium on fetal growth. sqLNS was started ≥3 mo prior to conception,","dates":{"release":"2026-01-01T00:00:00Z","publication":"2026 Feb","modification":"2026-07-16T03:11:39.218Z","creation":"2026-07-09T10:30:52.122Z"},"accession":"S-EPMC12863136","cross_references":{"pubmed":["41461273"],"doi":["10.1016/j.tjnut.2025.101279"]}}